Cardlytics CDLX 深 滬
等待開盤 08-21 09:30:00 美东时间
1.055
-0.045
-4.09%
華盛通- 最 高1.11
- 今 開1.07
- 成交量 131.70万股
- 最 低 1.03
- 昨 收 1.10
- 總市值 5616.49万
- 52周最高 5.245
- 市盈率 靜 --
- 換手率 2.47%
- 52周最低 1.03
- 委 比 -30.13%
- 總股本 5323.69万
- 歷史最高 161.47
- 量 比 0.98
- 振 幅 7.27%
- 歷史最低 1.03
- 每 手 1
- 風險率 3.33%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多10 Communication Services Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
08-12 01:35
Cardlytics shares are trading lower after the company reported worse-than-expected Q2 sales results and issued Q3 sales guidance below estimates.
Cardlytics shares are trading lower after the company reported worse-than-expec...
08-07 05:29
Cardlytics Sees Q3 Sales $52.200M-$58.200M vs $68.207M Est
Cardlytics (NASDAQ:CDLX) sees Q3 sales of $52.200 million-$58.200 million vs $68.207 million analyst estimate.
08-07 04:14
Cardlytics Q2 Adj. EPS $(0.13) Beats $(0.16) Estimate, Sales $63.200M Miss $64.019M Estimate
Cardlytics (NASDAQ:CDLX) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.16) by 20.25 percent. This is a 13.33 percent increase over losses of $(0.15) per share from the
08-07 04:14
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
美股牛股 | 财报大超华尔街预期，CRO公司Medpace飙涨近55%！法拉第未来大涨超43%
财报大超华尔街预期，CRO公司Medpace飙涨近55%！公司获高额预订单，法拉第未来大涨超43%；"Meme股"获散户持续热炒，柯尔百货涨超37%>
07-23 19:34
11 Communication Services Stocks Moving In Wednesday's After-Market Session
Gainers DHI Group (NYSE:DHX) stock increased by 7.3% to $2.8 during Wednesday'...
06-26 05:06
Candel Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors
Candel Therapeutics has appointed Maha Radhakrishnan, M.D., to its Board of Directors to strengthen its leadership team as it prepares to submit a Biologics License Application (BLA) for CAN-2409 in intermediate-to-high-risk prostate cancer by Q4 2026. Dr. Radhakrishnan brings over 20 years of experience in product development and commercialization, which will be instrumental in advancing Candel's late-stage oncology programs. CAN-2409, an off-th...
06-06 12:05
美股大行评级 | 潜在涨幅754.7%！HC Wainwright & Co.：Alector获机构升目标价至10美元，维持"买入"评级
潜在涨幅754.7%！HC Wainwright & Co.：Alector获机构升目标价至10美元，维持"买入"评级
05-10 10:00
Lake Street Maintains Hold on Cardlytics, Lowers Price Target to $2.5
Lake Street analyst Jacob Stephan maintains Cardlytics (NASDAQ:CDLX) with a Hold and lowers the price target from $3 to $2.5.
05-09 01:46
